Announcements and revisions of Australian macroeconomic data and their news content for Australian financial markets

Authors: Sedrani R.; Jones L.H.; Jutzi-Eme A.-M.; Schuler W.; Cottens S.; Brooks R.D.; Berman G.; Davidson S.; Tan T.-Y.

Source: Journal of International Financial Markets, Institutions & Money, Volume 9, Number 2, April 1999 , pp. 195-215(21)

Publisher: Elsevier

Keywords: Rapamycin; Immunosuppressant; Natural product derivation; Market efficiency; Macroeconomic announcements; Data revisions; [JEL classification codes] G14; [JEL classification codes] F30; [JEL classification codes] E44

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S1042-4431(99)00007-4

Affiliations: 1: aDepartment of Economics and Finance, Royal Melbourne Institute of Technology, GPO Box 2746V, Melbourne, Australia

Publication date: 1999-04-01

• In this: publication
• By this: publisher
• In this Subject: Finance
• By this author: Sedrani R. ;  Jones L.H. ;  Jutzi-Eme A.-M. ;  Schuler W. ;  Cottens S. ;  Brooks R.D. ;  Berman G. ;  Davidson S. ;  Tan T.-Y.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers